Vestal Point Capital »

Fulcrum Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.2M 1.2M 6.20

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Fulcrum Therapeutics

RA Capital Management
Rtw Investments
FMR
BlackRock
Vanguard Group
Cowen And Company
Caption Management
Suvretta Capital Management
Trv Gp Iv
Citadel Advisors
Logos Global Management
Dimensional Fund Advisors
MPM Oncology Impact Management
Leucadia National Corporation
Geode Capital Management

View all funds holding Fulcrum Therapeutics